1
|
Wyles SP, Monie DD, Paradise CR, Meyer FB, Hayden RE, Terzic A. Emerging workforce readiness in regenerative healthcare. Regen Med 2021; 16:197-206. [PMID: 33622054 PMCID: PMC8656339 DOI: 10.2217/rme-2020-0137] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
The biology of regenerative medicine has steadily matured, providing the foundation for randomized clinical trials and translation into validated applications. Today, the growing regenerative armamentarium is poised to impact disease management, yet a gap in training next-generation healthcare providers, equipped to adopt and deliver regenerative options, has been exposed. This special report highlights a multiyear experience in developing and deploying a comprehensive regenerative curriculum for medical trainees. For academicians and institutions invested in establishing a formalized regenerative medicine syllabus, the Regenerative Medicine and Surgery course provides a patient-focused prototype for next-generation learners, offering a dedicated educational experience that encompasses discovery, development and delivery of regenerative solutions. Built with the vision of an evolving regenerative care model, this transdisciplinary endeavor could serve as an adoptable education portal to advance the readiness of the emergent regenerative healthcare workforce globally.
Collapse
Affiliation(s)
- Saranya P Wyles
- Center for Regenerative Medicine, Mayo Clinic, Rochester, MN 55905, USA.,Department of Dermatology, Mayo Clinic, Rochester, MN 55905, USA.,Department of Molecular Pharmacology & Experimental Therapeutics, Rochester, MN 55905, USA
| | - Dileep D Monie
- Mayo Clinic Alix School of Medicine, Rochester, MN 55905, USA
| | | | - Fredric B Meyer
- Mayo Clinic Alix School of Medicine, Rochester, MN 55905, USA.,Department of Neurologic Surgery, Mayo Clinic, Rochester, MN 55905, USA
| | - Richard E Hayden
- Center for Regenerative Medicine, Mayo Clinic, Rochester, MN 55905, USA.,Department of Otolaryngology, Mayo Clinic, Phoenix, AZ 85054, USA
| | - Andre Terzic
- Center for Regenerative Medicine, Mayo Clinic, Rochester, MN 55905, USA.,Department of Molecular Pharmacology & Experimental Therapeutics, Rochester, MN 55905, USA.,Department of Cardiovascular Medicine, Rochester, MN 55905, USA.,Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA
| |
Collapse
|
2
|
Waldman SA, Terzic A. Health Care Evolves From Reactive to Proactive. Clin Pharmacol Ther 2019; 105:10-13. [PMID: 30597564 DOI: 10.1002/cpt.1295] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Scott A Waldman
- Division of Clinical Pharmacology, Department of Pharmacology and Experimental Therapeutics, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Andre Terzic
- Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|
3
|
Wyles SP, Terzic A. Building the regenerative medicine workforce of the future: an educational imperative. Regen Med 2019; 14:613-615. [DOI: 10.2217/rme-2019-0072] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Affiliation(s)
- Saranya P Wyles
- Mayo Clinic Department of Dermatology, Rochester, MN 55905, USA
- Mayo Clinic Center for Regenerative Medicine, Rochester, MN 55905, USA
| | - Andre Terzic
- Mayo Clinic Center for Regenerative Medicine, Rochester, MN 55905, USA
- Mayo Clinic Department of Cardiovascular Medicine, Rochester, MN 55905, USA
- Mayo Clinic Department of Molecular Pharmacology & Experimental Therapeutics, Rochester, MN 55905, USA
- Mayo Clinic Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA
| |
Collapse
|
4
|
Wyles SP, Hayden RE, Meyer FB, Terzic A. Regenerative medicine curriculum for next-generation physicians. NPJ Regen Med 2019; 4:3. [PMID: 30774984 PMCID: PMC6367326 DOI: 10.1038/s41536-019-0065-8] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2018] [Accepted: 01/07/2019] [Indexed: 12/17/2022] Open
Abstract
Regenerative sciences are poised to transform clinical practice. The quest for regenerative solutions has, however, exposed a major gap in current healthcare education. A call for evidence-based adoption has underscored the necessity to establish rigorous regenerative medicine educational programs early in training. Here, we present a patient-centric regenerative medicine curriculum embedded into medical school core learning. Launched as a dedicated portal of new knowledge, learner proficiency was instilled by means of a discovery–translation–application blueprint. Using the “from the patient to the patient” paradigm, student experience recognized unmet patient needs, evolving regenerative technologies, and ensuing patient management solutions. Targeted on the deployment of a regenerative model of care, complementary subject matter included ethics, regulatory affairs, quality control, supply chain, and biobusiness. Completion of learning objectives was monitored by online tests, group teaching, simulated clinical examinations along with longitudinal continuity across medical school training and residency. Success was documented by increased awareness and proficiency in domain-relevant content, as well as specialty identification through practice exposure, research engagement, clinical acumen, and education-driven practice advancement. Early incorporation into mainstream medical education offers a tool to train next-generation healthcare providers equipped to adopt and deliver validated regenerative medicine solutions.
Collapse
Affiliation(s)
- Saranya P Wyles
- Department of Dermatology, Rochester, MN USA.,2Mayo Clinic Center for Regenerative Medicine, Rochester, MN USA
| | - Richard E Hayden
- 2Mayo Clinic Center for Regenerative Medicine, Rochester, MN USA.,Department of Otolaryngology, Phoenix, AZ USA
| | - Fredric B Meyer
- 4Mayo Clinic Alix School of Medicine, Rochester, MN USA.,Department of Neurologic Surgery, Rochester, MN USA
| | - Andre Terzic
- 2Mayo Clinic Center for Regenerative Medicine, Rochester, MN USA.,Department of Cardiovascular Medicine, Rochester, MN USA.,Department of Molecular Pharmacology and Experimental Therapeutics, Rochester, MN USA.,8Department of Clinical Genomics, Mayo Clinic, Rochester, MN USA
| |
Collapse
|
5
|
Waldman SA, Terzic A. Process Improvement for Maximized Therapeutic Innovation Outcome. Clin Pharmacol Ther 2018; 103:8-12. [PMID: 29265398 PMCID: PMC5745039 DOI: 10.1002/cpt.929] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2017] [Accepted: 11/02/2017] [Indexed: 12/18/2022]
Abstract
Deconvoluting key biological mechanisms forms the framework for therapeutic discovery. Strategies that enable effective translation of those insights along the development and regulatory path ultimately drive validated clinical application in patients and populations. Accordingly, parity in What vs. How we transform novel mechanistic insights into therapeutic paradigms is essential in achieving success. Aligning molecular discovery with innovations in structures and processes along the discovery-development-regulation-utilization continuum maximizes the return on public and private investments for next-generation solutions in managing health and disease.
Collapse
Affiliation(s)
- Scott A Waldman
- Department of Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - Andre Terzic
- Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|
6
|
Waldman SA, Terzic A. Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics. Clin Pharmacol Ther 2017; 102:373-377. [PMID: 28782825 DOI: 10.1002/cpt.763] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2017] [Accepted: 06/08/2017] [Indexed: 11/08/2022]
Abstract
Clinical Pharmacology & Therapeutics (CPT) is an established voice of the discipline, a trusted source of new knowledge showcasing discovery, translation, and application of novel therapeutic paradigms to advance the management of patients and populations. Identifying, evaluating, prioritizing, and disseminating the best science along the discovery-development-regulatory-utilization continuum are responsibilities shared through peer review. To enhance the uniformity of this essential component of quality assurance and innovation, and maximize the value of the journal and its contents to authors, reviewers, and the readership, we review key concepts concerning peer review as it specifically relates to CPT.
Collapse
Affiliation(s)
- S A Waldman
- Department of Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
| | - A Terzic
- Mayo Clinic Center for Regenerative Medicine, Departments of Cardiovascular Medicine, Molecular Pharmacology and Experimental Therapeutics and Medical Genetics, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|